Antipsychotic Effects of Sorghum Bicolor (JOBELYN) in the Treatment of Schizophrenia
Condition(s):Schizophrenia and Disorders With Psychotic FeaturesLast Updated:February 16, 2017Unknown status
Hide Studies Not Open or Pending
Condition(s):Schizophrenia and Disorders With Psychotic FeaturesLast Updated:February 16, 2017Unknown status
Condition(s):DeliriumLast Updated:March 21, 2018Terminated
Condition(s):Schizophrenia; Schizoaffective DisorderLast Updated:August 6, 2012Completed
Condition(s):Cyclic Vomiting SyndromeLast Updated:November 28, 2023Terminated
Condition(s):Gynecological DiseaseLast Updated:September 9, 2020Completed
Condition(s):DeliriumLast Updated:January 18, 2023Active, not recruiting
Condition(s):DeliriumLast Updated:February 9, 2018Completed
Condition(s):Haloperidol; Advanced Cancer; Hyperactive Delirium; Olanzapine; End-stage Organ DiseaseLast Updated:October 28, 2022Recruiting
Condition(s):DeliriumLast Updated:November 26, 2015Completed
Condition(s):Cannabis Hyperemesis SyndromeLast Updated:August 10, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.